Atomoxetine, a selective norepinephrine (noradrenaline) reuptake inhibitor, is an effective and safe medication in the treatment of attention-deficit hyperactivity disorder (ADHD) with or without autism spectrum disorder (ASD) in children. However, unusual side effects may occur during the course of the treatment. In this case study, we present a 6-year-old child diagnosed with ASD comorbid with ADHD who developed atomoxetine induced mania during his treatment for ADHD.
To cite this article: Tanir Y, Turkmen G. Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder. Psychiatry and Clinical Psychopharmacology 2020;30(4):464-466